Stage‑specific survival has improved for young breast cancer patients since 2000: but not equally

We have investigated the association between CYP2D6 genotypes, serum concentrations of active tamoxifen metabolites, and long-term outcome in tamoxifen treated breast cancer

2 Kaplan–Meier estimates of overall survival in patients with brain-only metastases from breast cancer treated with upfront whole- brain radiotherapy vs.. surgical resection

The American Society of Clinical Oncology (ASCO), The Na- tional Comprehensive Cancer Network (NCCN) in the US and the Norwegian Breast Cancer Group (NBCG) all have guidelines for

Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review..

Kaplan-Meier curves, mortality rates and adjusted hazard ratios for breast cancer death were estimated by IHC subtypes, grade, tumour size and nodal status during 13 years

We analysed the overall survival and time trends in the incidence of breast and cervical can- cers and the mortality rate (2000–2015) among women using population-based cancer

The BRCA2 DDCV carriers were also at a higher risk of having a first-degree family history of breast cancer or ovarian cancer compared with the normal/polymorphic BRCA2 carriers

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised